Medicine
“Dancing” molecules repair spinal cord injuries in paralyzed mice
A treatment for spinal cord injuries was able to reverse paralysis in mice by “dancing” to connect with cells near the site of the injury.
DeepMind’s AI lights path to faster drug development
Alphabet has announced the launch of Isomorphic Labs, an AI-driven drug discovery company built on research from its DeepMind subsidiary.
Pfizer’s antiviral pill cuts COVID-19 hospitalization, death by 89%
Pfizer’s antiviral pill to treat COVID-19 cut the risk of hospitalization or death by 89%, according to early results from a phase 2/3 trial.
A new clue in why oral vaccines don’t work as well in developing countries
Oral vaccines are crucial to public health, but work worse where they are needed most. A new mouse study has a potential reason why.
Preventative breast cancer vaccine enters human trials
A breast cancer vaccine entering human trials is designed to prevent triple-negative breast cancer — the deadliest, most aggressive form.
Merck is making its COVID-19 antiviral pill more affordable to low-income countries
Drug maker Merck has agreed to license a promising antiviral pill to treat COVID-19 to low- and middle-income countries for free.
Cooling caps can help prevent chemo hair loss
Chemo hair loss is a common side effect for cancer patients, but cooling caps can help limit the loss.
HIV treatment gets green light for human trials
Excision BioTherapeutics is cleared to begin human trials of a CRISPR-based HIV treatment that’s administered in just one IV infusion.
Johns Hopkins receives the first NIH grant for clinical psychedelic research in half a century
For the first time in decades, the National Institutes of Health is funding a clinical psychedelic study, perhaps a turning point for the field.
New cardiac patch can be implanted with a syringe
A new cardiac patch developed by Canadian scientists could help repair heart damage by supporting tissue without blocking electrical activity.